JP2018521995A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521995A5
JP2018521995A5 JP2017566402A JP2017566402A JP2018521995A5 JP 2018521995 A5 JP2018521995 A5 JP 2018521995A5 JP 2017566402 A JP2017566402 A JP 2017566402A JP 2017566402 A JP2017566402 A JP 2017566402A JP 2018521995 A5 JP2018521995 A5 JP 2018521995A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
drinking water
medicinal
obtainable
isoxazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017566402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521995A (ja
JP6933983B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/064449 external-priority patent/WO2016207234A1/en
Publication of JP2018521995A publication Critical patent/JP2018521995A/ja
Publication of JP2018521995A5 publication Critical patent/JP2018521995A5/ja
Application granted granted Critical
Publication of JP6933983B2 publication Critical patent/JP6933983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017566402A 2015-06-23 2016-06-22 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液 Active JP6933983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15173454.8 2015-06-23
EP15173454 2015-06-23
PCT/EP2016/064449 WO2016207234A1 (en) 2015-06-23 2016-06-22 Isoxazoline solution containing vitamin e for use with sanitized drinking water

Publications (3)

Publication Number Publication Date
JP2018521995A JP2018521995A (ja) 2018-08-09
JP2018521995A5 true JP2018521995A5 (enExample) 2019-07-25
JP6933983B2 JP6933983B2 (ja) 2021-09-08

Family

ID=53488226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017566402A Active JP6933983B2 (ja) 2015-06-23 2016-06-22 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液

Country Status (10)

Country Link
US (3) US20180169073A1 (enExample)
EP (1) EP3313400B1 (enExample)
JP (1) JP6933983B2 (enExample)
CN (1) CN107750159B (enExample)
BR (1) BR112017027855B1 (enExample)
ES (1) ES2920394T3 (enExample)
HU (1) HUE059228T2 (enExample)
MX (1) MX383746B (enExample)
PL (1) PL3313400T3 (enExample)
WO (1) WO2016207234A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
KR102668200B1 (ko) * 2015-10-28 2024-05-23 주식회사유한양행 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물
UY40429A (es) 2016-02-24 2023-10-13 Boehringer Ingelheim Animal Health Usa Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
KR20250057155A (ko) 2017-12-15 2025-04-28 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
CA3164924A1 (en) 2019-12-18 2021-06-24 Elanco Tiergesundheit Ag Isoxazoline derivatives as pesticides
KR20230043904A (ko) 2020-07-24 2023-03-31 엘랑코 유에스 인코포레이티드 이속사졸린 화합물 및 이의 중간체의 제조 공정
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
BR112023017675A2 (pt) * 2021-03-11 2023-11-14 In The Bowl Animal Health Inc Alimento canino oral e métodos para controlar infestações de carrapatos em um canino
CN114306231B (zh) * 2021-12-29 2023-03-24 天津市中升挑战生物科技有限公司 一种氟雷拉纳杀虫剂及其制备方法和应用
CN115266988A (zh) * 2022-08-01 2022-11-01 江苏慧聚药业股份有限公司 一种氟雷拉钠有关物质的检测方法
CN117064851B (zh) * 2023-09-20 2026-02-17 中国农业大学 一种异噁唑啉类驱虫药制剂的制备方法
CN118477040B (zh) * 2024-04-11 2025-02-25 河北威远药业有限公司 一种氟雷拉纳溶液的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
EP1294644B1 (en) * 2000-06-27 2010-07-14 The Procter & Gamble Company Water treatment compositions
US20050005868A1 (en) * 2003-07-11 2005-01-13 Shepard Allan T. Animal drinking water production
CN1930136B (zh) 2004-03-05 2012-02-08 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物及有害生物防除剂
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
JP2007319124A (ja) * 2006-06-02 2007-12-13 Nippon Tablet Kk 健康食品
KR20090130064A (ko) 2007-04-10 2009-12-17 바이엘 크롭사이언스 아게 살충성 아릴 이속사졸린 유도체
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
EP2182945B1 (en) 2007-06-27 2015-08-05 E. I. du Pont de Nemours and Company Animal pest control method
US20090024541A1 (en) * 2007-07-20 2009-01-22 Gary Kremen Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
EP2306837B2 (en) * 2008-07-09 2023-10-25 Basf Se Pesticidal active mixtures comprising isoxazoline compounds i
US7951404B2 (en) 2008-07-11 2011-05-31 Sanosil Ag Concentrate for preparing a disinfectant and methods for its preparation and use
US8377942B2 (en) 2008-12-18 2013-02-19 Novartis Ag Isoxazolines derivatives and their use as pesticide
RU2518462C2 (ru) 2008-12-19 2014-06-10 Новартис Аг Органические соединения
ES2569486T3 (es) 2009-12-17 2016-05-11 Merial, Inc. Compuestos de dihidroazol antiparasitarios y composiciones que comprenden los mismos
US8999889B2 (en) * 2010-02-01 2015-04-07 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
CA2794428A1 (en) 2010-04-08 2011-10-13 Pfizer Inc. Substituted 3,5-diphenyl-isoxazoline derivatives as insecticides and acaricides
WO2012155352A1 (en) 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
WO2013026695A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
CN103764644A (zh) 2011-08-25 2014-04-30 先正达参股股份有限公司 作为杀虫化合物的异噁唑啉衍生物
RS61048B1 (sr) * 2011-09-12 2020-12-31 Boehringer Ingelheim Animal Health Usa Inc Paraziticidne kompozicije koje sadrže izoksazolin aktivni agens, postupak i njihove primene
HRP20250874T1 (hr) 2013-09-30 2025-09-26 Zoetis Services Llc Dugodjelujuće formulacije spiro‑izoksazolina
US9371293B2 (en) 2013-10-25 2016-06-21 Sumitomo Chemical Company, Limited Isoxazoline compound composition
US9447084B2 (en) 2013-11-01 2016-09-20 Merial, Inc. Antiparisitic and pesticidal isoxazoline compounds
RU2673723C1 (ru) * 2013-12-10 2018-11-29 Интервет Интернэшнл Б.В. Применение содержащих изоксазолин соединений в качестве противопаразитарных средств
PT4306168T (pt) * 2013-12-20 2025-07-24 Intervet Int Bv Composições de isoxazolina e utilização das mesmas na prevenção ou tratamento de infestações parasitárias em animais
EP3878281B1 (en) * 2013-12-20 2023-05-24 Intervet International B.V. Use of isoxazoline compounds in poultry
CA2965524C (en) * 2014-11-03 2020-04-14 Zoetis Services Llc Palatable chewable veterinary composition

Similar Documents

Publication Publication Date Title
JP2018521995A5 (enExample)
JP2016540809A5 (enExample)
JP2014504586A5 (enExample)
JP2014506249A5 (enExample)
RU2016129474A (ru) Изоксазолиновые композиции
JP2017538767A5 (enExample)
JP2016540028A5 (enExample)
RU2013135280A (ru) Состав изоксазолина для местного и наружного применения
JP2013510124A5 (enExample)
JP2016507472A5 (enExample)
EA201490647A1 (ru) Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции
RU2017126029A (ru) Применение изоксазолиновых соединений для лечения демодекоза
RU2015123737A (ru) Производство полупластичных фармацевтических препаратов
EA201790389A1 (ru) Пирролопиримидиновые соединения, используемые в качестве агониста tlr7
RU2014144360A (ru) Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений
JP2013545785A5 (enExample)
JP2016503799A5 (enExample)
JP2005508967A5 (enExample)
PE20190328A1 (es) Compuestos de carfilzomib pegilados
SI2978752T1 (en) 6- (5-Hydroxy-1H-pyrazol-1-yl) nicotinamide derivatives and their use as inhibitors of PHD
RU2010143857A (ru) Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибриторов parp и ингибиторов полимеризации тубулина
JP2017517512A5 (enExample)
EA032951B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
AR037350A1 (es) Derivados de piperidina, proceso para preparar estos compuestos, composicion farmaceutica, y uso de estos compuestos para la manufactura de un medicamento util para el tratamiento de una enfermedad mediada por ccr5 (tal como artritis reumatoidea)
RU2481344C2 (ru) Замещенные (оксазолидинон-5-ил-метил)-2-тиофен-карбоксамиды и их применение в сфере свертывания крови